Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

102.49
-0.3700-0.36%
Post-market: 102.490.00000.00%19:30 EDT
Volume:87.75K
Turnover:8.99M
Market Cap:4.32B
PE:-99.67
High:102.87
Open:102.55
Low:102.15
Close:102.86
52wk High:107.69
52wk Low:85.36
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.24
T/O Rate:0.21%
Dividend:1.38
Dividend Rate:1.34%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.12
PE(LYR):-99.67

Loading ...

Human Health Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

TIPRANKS
·
Sep 16

HeraMED Secures Full-Scale Digital Maternity Rollout with US Health System Lee Health

TIPRANKS
·
Sep 16

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

UnitedHealth Group Announces Earnings Release Date

THOMSON REUTERS
·
Sep 16

Health Rounds: New Dye for MRI Exams Detects Lung Cancer Earlier

Reuters
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Sep 15

LIVE Markets-Autumn in New York: Factory Expansion Slows, Input Prices at Multi-Year Highs - Empire State

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

LIVE Markets-US Stock Indexes Swing Lower as Oil, Yields Jump

Reuters
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Sep 15

Covista to invest $150,000 in The Health Collaborative

TIPRANKS
·
Sep 15

Gix Makes Strategic Investment in Ottonomy, a Physical AI, L4 Autonomy and Robotics Technology Company

GlobeNewswire
·
Sep 15